According to Regeneron Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $13.11 B. In 2022 the company made a revenue of $12.17 B a decrease over the years 2021 revenue that were of $16.07 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $13.11 B | 7.76% |
2022 | $12.17 B | -24.26% |
2021 | $16.07 B | 89.14% |
2020 | $8.49 B | 23.8% |
2019 | $6.86 B | 2.28% |
2018 | $6.71 B | 14.28% |
2017 | $5.87 B | 20.82% |
2016 | $4.86 B | 18.44% |
2015 | $4.10 B | 45.55% |
2014 | $2.81 B | 33.96% |
2013 | $2.10 B | 52.69% |
2012 | $1.37 B | 209.2% |
2011 | $0.44 B | -2.89% |
2010 | $0.45 B | 21.04% |
2009 | $0.37 B | 59.05% |
2008 | $0.23 B | 90.73% |
2007 | $0.12 B | 97.05% |
2006 | $63.44 M | -4.15% |
2005 | $66.19 M | -61.96% |
2004 | $0.17 B | 201.55% |
2003 | $57.7 M | 162.45% |
2002 | $21.98 M | 0.07% |
2001 | $21.97 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 609.16% | ๐บ๐ธ USA |
Novartis NVS | $51.01 B | 288.89% | ๐จ๐ญ Switzerland |
Amgen AMGN | $28.19 B | 114.91% | ๐บ๐ธ USA |
Sanofi SNY | $50.35 B | 283.92% | ๐ซ๐ท France |
Biogen BIIB | $9.83 B | -25.02% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $1.82 B | -86.06% | ๐บ๐ธ USA |